Clearside Biomedical Announces Presentations on its Suprachoroidal Space Injection Platform at Upcoming Medical Meetings
Clearside Biomedical announced that multiple presentations will be made on Clearside’s Suprachoroidal Space (SCS) injection platform at upcoming ophthalmology and gene therapy medical meetings in Vancouver, British Columbia. The presentations will highlight the benefits of the company’s SCS injection platform when utilized in uveitis patients and with gene therapy.
Viral Kansara, PhD, Clearside Vice President, Discovery, will give an oral presentation at the 6th Annual Retinal Cell and Gene Therapy Innovation Summit
Title: | Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbits |
Date: | Friday, April 26, 2019 |
Time: | 5:30 pm – 5:45 pm |
Eric B. Suhler MD, MPH, Oregon Health and Science University Professor of Ophthalmology and Co-Director, OHSU Uveitis Clinic, will give an oral presentation at the American Uveitis Society Spring Meeting 2019
Title: | Suprachoroidal Administration of Triamcinolone Acetonide (CLS-TA) For the Treatment of Macular Edema in Noninfectious Uveitis: Pooled Results of Three Clinical Trials |
Date: | Saturday, April 27, 2019 |
Event Time: | 5:00 pm – 7:30 pm |
Three poster presentations will be made at the Association for Research in Vision and Ophthalmology (ARVO) 2019 Conference taking place April 28 – May 2, 2019
Title: | Suprachoroidal injection of AAV8 for ocular gene delivery in the nonhuman primate |
Date: | Tuesday, April 30, 2019 |
Time: | 8:45 am – 10:30 am |
Session: | Gene Therapy and Delivery |
Poster #: | A0091 |
Abstract #: | 2904 – A0091 |
|
|
Title: | Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbits |
Date: | Tuesday, April 30, 2019 |
Time: | 8:45 am – 10:30 am |
Session: | Gene Therapy and Delivery |
Poster #: | A0096 |
Abstract #: | 2909 – A0096 |
Title: | Treatment response analysis of visual acuity and central subfield retinal thickness following suprachoroidal CLS-TA |
Date: | Tuesday, April 30, 2019 |
Time: | 11:45 am – 1:30 pm |
Session: | Uveitis and scleritis – clinical therapeutics and checkpoint inhibitors |
Poster #: | A0552 |
Abstract #: | 3511 – A0552 |